206 related articles for article (PubMed ID: 28536806)
21. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?
Adam R; de Haas RJ; Wicherts DA; Aloia TA; Delvart V; Azoulay D; Bismuth H; Castaing D
J Clin Oncol; 2008 Aug; 26(22):3672-80. PubMed ID: 18669451
[TBL] [Abstract][Full Text] [Related]
22. Significance of R1 Resection for Advanced Colorectal Liver Metastases in the Era of Modern Effective Chemotherapy.
Laurent C; Adam JP; Denost Q; Smith D; Saric J; Chiche L
World J Surg; 2016 May; 40(5):1191-9. PubMed ID: 26757718
[TBL] [Abstract][Full Text] [Related]
23. Increased carcinoembryonic antigen (CEA) following neoadjuvant chemotherapy predicts poor prognosis in patients that undergo hepatectomy for liver-only colorectal metastases.
Neofytou K; Giakoustidis A; Neves MC; Morrison D; Giakoustidis D; Khan AZ; Stebbing J; Mudan S
Langenbecks Arch Surg; 2017 Jun; 402(4):599-605. PubMed ID: 27043945
[TBL] [Abstract][Full Text] [Related]
24. Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.
Ichida H; Mise Y; Ito H; Ishizawa T; Inoue Y; Takahashi Y; Shinozaki E; Yamaguchi K; Saiura A
World J Surg Oncol; 2019 Jun; 17(1):100. PubMed ID: 31196104
[TBL] [Abstract][Full Text] [Related]
25. The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting.
Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Williams R; Cunningham D; Mudan S
Ann Surg Oncol; 2015 Dec; 22(13):4353-62. PubMed ID: 25773876
[TBL] [Abstract][Full Text] [Related]
26. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
[TBL] [Abstract][Full Text] [Related]
27. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
[TBL] [Abstract][Full Text] [Related]
28. Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases.
Devaud N; Kanji ZS; Dhani N; Grant RC; Shoushtari H; Serrano PE; Nanji S; Greig PD; McGilvray I; Moulton CA; Wei A; Gallinger S; Cleary SP
HPB (Oxford); 2014 May; 16(5):475-80. PubMed ID: 23927606
[TBL] [Abstract][Full Text] [Related]
29. CALy Prognostic Score (CEA, ALP, Lymphocyte Count) as a predictor of survival after hepatectomy for liver-only colorectal metastases.
Neofytou K; Giakoustidis A; Mudan S
J BUON; 2015; 20(3):746-55. PubMed ID: 26214626
[TBL] [Abstract][Full Text] [Related]
30. Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation.
Vogl TJ; Lahrsow M; Albrecht MH; Hammerstingl R; Thompson ZM; Gruber-Rouh T
Eur J Radiol; 2018 May; 102():138-145. PubMed ID: 29685527
[TBL] [Abstract][Full Text] [Related]
31. Equivalent survival in patients with and without steatosis undergoing resection for colorectal liver metastases following pre-operative chemotherapy.
Parkin E; O'Reilly DA; Adam R; Kaiser GM; Laurent C; Elias D; Capussotti L; Renehan AG;
Eur J Surg Oncol; 2014 Nov; 40(11):1436-44. PubMed ID: 25189474
[TBL] [Abstract][Full Text] [Related]
32. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
[TBL] [Abstract][Full Text] [Related]
33. Portal vein embolization does not affect the long-term survival and risk of cancer recurrence among colorectal liver metastases patients: A prospective cohort study.
Collin Y; Paré A; Belblidia A; Létourneau R; Plasse M; Dagenais M; Turcotte S; Martel G; Roy A; Lapointe R; Vandenbroucke-Menu F
Int J Surg; 2019 Jan; 61():42-47. PubMed ID: 30537548
[TBL] [Abstract][Full Text] [Related]
34. Feasibility and potential benefit of preoperative chemotherapy for colorectal liver metastasis (CLM): a single-centered retrospective study.
Kataoka K; Kanazawa A; Nakajima A; Yamaguchi A; Arimoto A; Kohno Y
Surg Today; 2013 Oct; 43(10):1154-61. PubMed ID: 23139049
[TBL] [Abstract][Full Text] [Related]
35. Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases.
Gulubova M; Manolova I; Kyurkchiev D; Julianov A; Altunkova I
APMIS; 2009 Dec; 117(12):870-9. PubMed ID: 20078551
[TBL] [Abstract][Full Text] [Related]
36. Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases.
Kawamura J; Yazawa T; Sumida K; Kida Y; Ogawa R; Tani M; Kawasoe J; Yamamoto M; Harada H; Yamamoto H; Zaima M
World J Surg Oncol; 2016 Feb; 14():56. PubMed ID: 26911142
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of
Shim JR; Lee SD; Han SS; Lee SJ; Lee DE; Kim SK; Kim SH; Park SJ; Oh JH
Eur J Surg Oncol; 2018 May; 44(5):670-676. PubMed ID: 29459018
[TBL] [Abstract][Full Text] [Related]
38. Impact of RAS mutations on the immune infiltrate of colorectal liver metastases: A preliminary study.
Polidoro MA; Milana F; Soldani C; Franceschini B; Anselmo A; Colombo FS; Di Tommaso L; Cimino M; Carnevale S; Lleo A; Jaillon S; Torzilli G; Donadon M
J Leukoc Biol; 2020 Aug; 108(2):715-721. PubMed ID: 32108374
[TBL] [Abstract][Full Text] [Related]
39. Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases.
Kumar R; Dennison AR; Robertson V; Jones MJ; Neal CP; Garcea G
ANZ J Surg; 2018 Jan; 88(1-2):E16-E20. PubMed ID: 27621179
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]